Sandbox Reserved 1493
From Proteopedia
| Line 116: | Line 116: | ||
Also, as clotting advances, interactions between αIIbβ3 and the ligand evolve. The new contacts appearing between the integrin and bound soluble fibrin makes the ligand appear like an insoluble fibrinogen matrix which progressively provokes clot retraction. | Also, as clotting advances, interactions between αIIbβ3 and the ligand evolve. The new contacts appearing between the integrin and bound soluble fibrin makes the ligand appear like an insoluble fibrinogen matrix which progressively provokes clot retraction. | ||
| - | == Disease == | + | == Disease and relevance == |
| - | == Relevance == | ||
| - | == Structural highlights == | ||
| - | |||
| - | This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
| + | |||
| + | Structure: | ||
| + | <ref group='xtra'></ref><ref group='xtra'></ref><ref group='xtra'></ref><ref group='xtra'></ref><ref group='xtra'></ref> | ||
| + | <references group="xtra"/> | ||
| + | |||
| + | Function: | ||
| + | <ref group='xtra'>DOI: 10.1074/jbc.M113.518126</ref><ref group='xtra'></ref><ref group='xtra'></ref><ref group='xtra'></ref><ref group='xtra'></ref> | ||
| + | <references group="xtra"/> | ||
| + | |||
| + | Activity modulation: | ||
| + | <ref group='xtra'>DOI: 10.1021/bi1009858</ref><ref group='xtra'>DOI: 10.1074/jbc.M113.518126</ref><ref group='xtra'></ref><ref group='xtra'></ref> | ||
| + | <references group="xtra"/> | ||
| + | |||
| + | Diseases and relevance: | ||
| + | <ref group='xtra'>DOI: 10.1161/ATVBAHA.114.303411</ref><ref group='xtra'>DOI: 10.1161/CIRCRESAHA.112.300570</ref><ref group='xtra'>DOI: 10.1172/JCI119780</ref><ref group='xtra'></ref><ref group='xtra'></ref><ref group='xtra'></ref><ref group='xtra'></ref><ref group='xtra'></ref> | ||
| + | <references group="xtra"/> | ||
<references/> | <references/> | ||
Revision as of 11:55, 11 January 2019
| This Sandbox is Reserved from 06/12/2018, through 30/06/2019 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1480 through Sandbox Reserved 1543. |
To get started:
More help: Help:Editing |
Integrin αIIbβ3 (2VDL)
Integrin αIIbβ3 (or glycoprotein IIb/IIIa) is a complex present on the membrane of platelets that intervenes in the activation, adherence and aggregation of platelets during clotting. It is a cation-dependant heterodimeric transmembrane receptor containing a large extracellular headpiece and short intracellular tails. It is synthesized in megakaryocytes.
Its particular shape and localisation on the membrane allows both ligand binding and transduction of the activation signal. It is the dominant integrin on platelets with 70,000 to 90,000 receptors expressed on each platelet in the resting state.
The headpiece (2VDL) of integrin αIIbβ3 enables cation-facilitated ligand binding with multiple ligands (most known being fibrinogen, fibronectin, von Willebrand factors, thrombospondin and vitronectin). Binding affinity is dynamic and depends on the conformational status of the receptor.
| |||||||||||
References
Structure:
Cite error: Invalid <ref> tag;
refs with no name must have contentCite error: Invalid <ref> tag;
refs with no name must have contentCite error: Invalid <ref> tag;
refs with no name must have contentCite error: Invalid <ref> tag;
refs with no name must have contentCite error: Invalid <ref> tag;
refs with no name must have content
Function:
Cite error: Invalid <ref> tag;
refs with no name must have contentCite error: Invalid <ref> tag;
refs with no name must have contentCite error: Invalid <ref> tag;
refs with no name must have contentCite error: Invalid <ref> tag;
refs with no name must have content
- Podolnikova NP, Yakovlev S, Yakubenko VP, Wang X, Gorkun OV, Ugarova TP. The interaction of integrin alphaIIbbeta3 with fibrin occurs through multiple binding sites in the alphaIIb beta-propeller domain. J Biol Chem. 2014 Jan 24;289(4):2371-83. doi: 10.1074/jbc.M113.518126. Epub 2013 , Dec 12. PMID:24338009 doi:http://dx.doi.org/10.1074/jbc.M113.518126
Activity modulation:
Cite error: Invalid <ref> tag;
refs with no name must have contentCite error: Invalid <ref> tag;
refs with no name must have content
- Hantgan RR, Stahle MC, Lord ST. Dynamic regulation of fibrinogen: integrin alphaIIbbeta3 binding. Biochemistry. 2010 Nov 2;49(43):9217-25. doi: 10.1021/bi1009858. PMID:20828133 doi:http://dx.doi.org/10.1021/bi1009858
- Podolnikova NP, Yakovlev S, Yakubenko VP, Wang X, Gorkun OV, Ugarova TP. The interaction of integrin alphaIIbbeta3 with fibrin occurs through multiple binding sites in the alphaIIb beta-propeller domain. J Biol Chem. 2014 Jan 24;289(4):2371-83. doi: 10.1074/jbc.M113.518126. Epub 2013 , Dec 12. PMID:24338009 doi:http://dx.doi.org/10.1074/jbc.M113.518126
Diseases and relevance:
Cite error: Invalid <ref> tag;
refs with no name must have contentCite error: Invalid <ref> tag;
refs with no name must have contentCite error: Invalid <ref> tag;
refs with no name must have contentCite error: Invalid <ref> tag;
refs with no name must have contentCite error: Invalid <ref> tag;
refs with no name must have content
- Estevez B, Shen B, Du X. Targeting integrin and integrin signaling in treating thrombosis. Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):24-9. doi:, 10.1161/ATVBAHA.114.303411. Epub 2014 Sep 25. PMID:25256236 doi:http://dx.doi.org/10.1161/ATVBAHA.114.303411
- Bledzka K, Smyth SS, Plow EF. Integrin alphaIIbbeta3: from discovery to efficacious therapeutic target. Circ Res. 2013 Apr 12;112(8):1189-200. doi: 10.1161/CIRCRESAHA.112.300570. PMID:23580774 doi:http://dx.doi.org/10.1161/CIRCRESAHA.112.300570
- Wang R, Shattil SJ, Ambruso DR, Newman PJ. Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex. J Clin Invest. 1997 Nov 1;100(9):2393-403. doi: 10.1172/JCI119780. PMID:9351872 doi:http://dx.doi.org/10.1172/JCI119780
